<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1006">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05148052</url>
  </required_header>
  <id_info>
    <org_study_id>Stroke-VR-U/Ex</org_study_id>
    <nct_id>NCT05148052</nct_id>
  </id_info>
  <brief_title>Effect of Upper Extremity Rehabilitation Using Immersive Virtual Reality in Chronic Stroke Patients.</brief_title>
  <official_title>Effect of Upper Extremity Rehabilitation Using Fully-immersive Virtual Reality for Motor Recovery in Chronic Stroke Patients: A Prospective, Multicenter, Single-blind, Explorative, Randomized Crossover Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Traffic Injury Rehabilitation Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Korea Workers' Compensation and Welfare Service Incheon Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aimed to investigate the effect of exergames using virtual reality with head&#xD;
      mounted device on motor recovery of upper extremities in chronic stroke patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a crossover study for comparing conventional occupational therapy and exercise with&#xD;
      game format using virtual reality (virtual reality exergame). The virtual reality exergame is&#xD;
      designed to maximize the movement of upper extremities, primary to the shoulder and elbow.&#xD;
      Thirty-six chronic stroke patient will receive conventional occupational treatment and&#xD;
      virtual reality exergame in random order with a two-week-washout period. Outcome measures&#xD;
      will be evaluated within two days before and after each treatment, conventional treatment and&#xD;
      virtual reality exergame.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2022</start_date>
  <completion_date type="Anticipated">June 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Action Research Arm Test</measure>
    <time_frame>Within 2 days after the end of each intervention</time_frame>
    <description>As an upper extremity function evaluation tool, it tests grasp, grip, pinch, and gross arm movement function as sub-tests.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Box and Block test</measure>
    <time_frame>Within 2 days after the end of each intervention</time_frame>
    <description>an upper extremity function evaluation tool</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fugl-Meyer (FM) Assessment</measure>
    <time_frame>Within 2 days after the end of each intervention</time_frame>
    <description>an upper extremity function evaluation tool</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Barthel Index</measure>
    <time_frame>Within 2 days after the end of each intervention</time_frame>
    <description>an evaluation tool for assessing activities of daily living</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grip strength</measure>
    <time_frame>Within 2 days after the end of each intervention</time_frame>
    <description>Strength of hand grip, palmar pinch and lateral pinch power measured by grip force meter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory (BDI)</measure>
    <time_frame>Within 2 days after the end of each intervention</time_frame>
    <description>an evaluation tool for severity of depression in normal and psychiatric populations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Simulator Sickness Questionnaire</measure>
    <time_frame>Day 1 and Day 12 of virtual reality exergames intervention</time_frame>
    <description>an evaluation tool for assessing the subjective severity of simulator sickness symptoms</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Conventional therapy first</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group receiving conventional occupational therapy first and then virtual reality exergames.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Virtual reality first</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group receiving virtual reality exergames with virtual reality first and then conventional occupational therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Virtual reality exergames</intervention_name>
    <description>Twelve sessions of virtual reality exergames involving upper extremities will be conducted. Each session is 30 minutes and will be held 3 times a week. The washout period between the two types of interventions is 2 weeks.</description>
    <arm_group_label>Conventional therapy first</arm_group_label>
    <arm_group_label>Virtual reality first</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Conventional occupational therapy</intervention_name>
    <description>Conventional occupational therapy involving upper extremities will be conducted. Each session is 30 minutes and will be held 3 times a week. The washout period between the two types of interventions is 2 weeks.</description>
    <arm_group_label>Conventional therapy first</arm_group_label>
    <arm_group_label>Virtual reality first</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Chronic stroke patients who have passed 6 months or more without additional stroke&#xD;
             after the first stroke&#xD;
&#xD;
          -  Patients with upper extremity dysfunction due to stroke (ischemic, hemorrhagic)&#xD;
&#xD;
          -  Patients who can move the upper extremity against gravity with a manual muscle test of&#xD;
             grade 3 or higher in the affected shoulder and elbow, respectively&#xD;
&#xD;
          -  Patients who can stably maintain a sitting position&#xD;
&#xD;
          -  Patients who voluntarily agreed to participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with moderate or severe cognitive impairment with a score of 18 or less on&#xD;
             the Mini-Mental Status Examination (K-MMSE)&#xD;
&#xD;
          -  Patients with other causes of upper extremity dysfunction, such as peripheral nerve&#xD;
             damage, joint disease, etc.&#xD;
&#xD;
          -  Patients with a history of severe vertigo or epilepsy&#xD;
&#xD;
          -  Patients with medical reasons such as medical conditions that make it difficult to&#xD;
             participate in research&#xD;
&#xD;
          -  Patients who may be pregnant or who are pregnant or lactating&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Han Gil Seo, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Han Gil Seo, MD, PhD</last_name>
    <phone>82-2-2072-1659</phone>
    <email>hgseo80@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Korea Workers' Compensation &amp; Welfare Service Incheon Hospital</name>
      <address>
        <city>Incheon</city>
        <zip>21417</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <contact>
      <last_name>Min-Yong Lee, MD</last_name>
      <email>roado10@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>05505</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <contact>
      <last_name>Seung Hak Lee, MD, PhD</last_name>
      <email>seunghak@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Korea Worker's Compensation and Welfare Service Incheon Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>12564</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <contact>
      <last_name>Hye Jung Park, MD</last_name>
      <email>petitehj01@naver.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 12, 2021</study_first_submitted>
  <study_first_submitted_qc>November 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 8, 2021</study_first_posted>
  <last_update_submitted>November 23, 2021</last_update_submitted>
  <last_update_submitted_qc>November 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Han Gil Seo</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Virtual reality</keyword>
  <keyword>Upper Extremity Paresis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

